Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.

Academic radiology

Volumn 3 Suppl 2, Issue , 1996, Pages

  Frank, J A ^a   Bash, C ^a   Stone, L ^a   Petrella, J ^a   Maloni, H ^a   McFarland, H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOLINIUM PENTETATE; IMMUNOLOGICAL ADJUVANT; INTERFERON BETA SERINE; INTERFERON BETA-1B; MEGLUMINE; ORGANOMETALLIC COMPOUND; PENTETIC ACID;

ADULT; ARTICLE; BRAIN; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELINATED NERVE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ADJUVANTS, IMMUNOLOGIC; ADULT; BRAIN; CONTRAST MEDIA; DRUG COMBINATIONS; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID;

MLCS; MLOWN;

EID: 0030210741     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1076-6332(96)80525-3     Document Type: Article

References (0)